MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes.
ASH1L
MRG15
NMR
SAM
dynamics
inhibitors
methylation
nucleosomes
structure
Journal
Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697
Informations de publication
Date de publication:
05 10 2023
05 10 2023
Historique:
received:
18
03
2023
revised:
16
05
2023
accepted:
05
07
2023
medline:
9
10
2023
pubmed:
2
8
2023
entrez:
1
8
2023
Statut:
ppublish
Résumé
ASH1L is a histone methyltransferase that regulates gene expression through methylation of histone H3 on lysine K36. While the catalytic SET domain of ASH1L has low intrinsic activity, several studies found that it can be vastly enhanced by the interaction with MRG15 protein and proposed allosteric mechanism of releasing its autoinhibited conformation. Here, we found that full-length MRG15, but not the MRG domain alone, can enhance the activity of the ASH1L SET domain. In addition, we showed that catalytic activity of MRG15-ASH1L depends on nucleosome binding mediated by MRG15 chromodomain. We found that in solution MRG15 binds to ASH1L, but has no impact on the conformation of the SET domain autoinhibitory loop or the S-adenosylmethionine cofactor binding site. Moreover, MRG15 binding did not impair the potency of small molecule inhibitors of ASH1L. These findings suggest that MRG15 functions as an adapter that enhances ASH1L catalytic activity by recruiting nucleosome substrate.
Identifiants
pubmed: 37527654
pii: S0969-2126(23)00244-7
doi: 10.1016/j.str.2023.07.001
pii:
doi:
Substances chimiques
Nucleosomes
0
Transcription Factors
0
DNA-Binding Proteins
0
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
Histone Methyltransferases
EC 2.1.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1200-1207.e5Subventions
Organisme : NCI NIH HHS
ID : R01 CA207272
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244254
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests T.C. and J.G. received prior research support from Kura Oncology Inc. for an unrelated project, served as consultants for Kura Oncology, and have equity ownership in the company. The remaining authors declare no conflict of interest.